{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:30Z","timestamp":1789913670697,"version":"4.0.1"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["560943\/2010-5, 301526\/2015-0, 486618\/2013-7"],"award-info":[{"award-number":["560943\/2010-5, 301526\/2015-0, 486618\/2013-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01373-14, APQ-01661-1, APQ-01008-14, PPM-00710-15"],"award-info":[{"award-number":["APQ-01373-14, APQ-01661-1, APQ-01008-14, PPM-00710-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01043","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T12:58:42Z","timestamp":1526043522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":85,"title":["Peptide Vaccines for Leishmaniasis"],"prefix":"10.3389","volume":"9","author":[{"given":"Rory C. F.","family":"De Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamille M. De O.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi E. S.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao F.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A. S.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Dian D. O.","family":"Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeronimo C.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela de M.","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre B.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","article-title":"Leishmaniasis: new approaches to disease control","volume":"326","author":"Davies","year":"2003","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1590\/S0102-311X2008001200024","article-title":"Visceral leishmaniasis in Brazil: trends and challenges","volume":"24","author":"Maia-Elkhoury","year":"2008","journal-title":"Cad Saude Publica"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0005739","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis \u2013 implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1016\/j.vaccine.2004.03.058","article-title":"Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran","volume":"22","author":"Mohebali","year":"2004","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3389\/fimmu.2017.01763","article-title":"Identification of potential MHC class-II-restricted epitopes derived from Leishmania donovani antigens by reverse vaccinology and evaluation of their CD4+ T-cell responsiveness against visceral leishmaniasis","volume":"8","author":"Dikhit","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1700674","article-title":"Live attenuated Leishmania donovani centrin gene-deleted parasites induce IL-23-dependent IL-17-protective immune response against visceral leishmaniasis in a murine model","volume":"200","author":"Banerjee","year":"2018","journal-title":"J Immunol"},{"key":"B12","first-page":"35","article-title":"First generation leishmaniasis vaccines in clinical development: moving, but what next?","volume":"2","author":"Modabber","year":"2000","journal-title":"Curr Opin Anti Infect Investig Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e49780","DOI":"10.1371\/journal.pone.0049780","article-title":"Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation","volume":"7","author":"Roatt","year":"2012","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Carcelen","year":"2009","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1297-9716-45-69","article-title":"The protective immune response produced in dogs after primary vaccination with the LiESP\/QA-21 vaccine (CaniLeish(R)) remains effective against an experimental challenge one year later","volume":"45","author":"Martin","year":"2014","journal-title":"Vet Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1371\/journal.pntd.0003213","article-title":"A randomised, double-blind, controlled efficacy trial of the LiESP\/QA-21 vaccine in naive dogs exposed to two Leishmania infantum transmission seasons","volume":"8","author":"Oliva","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B20","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative review article","volume":"6","author":"Rezvan","year":"2015","journal-title":"Vet Res Forum"},{"key":"B21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/infdis\/jir842","article-title":"Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis","volume":"205","author":"Maroof","year":"2012","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/c5sc03892h","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral leishmaniasis: advancements in vaccine development via classical and molecular approaches","volume":"5","author":"Joshi","year":"2014","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"234ra256","DOI":"10.1126\/scitranslmed.3008222","article-title":"Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis","volume":"6","author":"Das","year":"2014","journal-title":"Sci Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e7880","DOI":"10.1371\/journal.pone.0007880","article-title":"Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral leishmaniasis in experimental mouse model","volume":"4","author":"Sachdeva","year":"2009","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.4161\/hv.21881","article-title":"Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines","volume":"8","author":"Elfaki","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","article-title":"Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells","volume":"26","author":"Resende","year":"2008","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e110014","DOI":"10.1371\/journal.pone.0110014","article-title":"Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis","volume":"9","author":"Costa","year":"2014","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13071-015-0964-5","article-title":"A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis","volume":"8","author":"Martins","year":"2015","journal-title":"Parasit Vectors"},{"key":"B34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.micinf.2017.03.002","article-title":"Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects","volume":"19","author":"Mahantesh","year":"2017","journal-title":"Microbes Infect"},{"key":"B35","first-page":"3","article-title":"Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major","volume":"72","author":"Yang","year":"1991","journal-title":"Immunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1084\/jem.172.2.645","article-title":"Immunoprotective Leishmania major synthetic T cell epitopes","volume":"172","author":"Jardim","year":"1990","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.4049\/jimmunol.150.10.4713","article-title":"Mapping human T cell epitopes in Leishmania gp63: identification of cross-reactive and species-specific epitopes","volume":"150","author":"Russo","year":"1993","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/0264-410X(95)00245-V","article-title":"Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine","volume":"14","author":"Frankenburg","year":"1996","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0264-410X(98)00363-6","article-title":"Long-term protection of mice against Leishmania major with a synthetic peptide vaccine","volume":"17","author":"Spitzer","year":"1999","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/039463200401700314","article-title":"Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis","volume":"17","author":"Tsagozis","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B41","first-page":"27","article-title":"Immunogenicity of MHC class I peptides derived from Leishmania mexicana Gp63 in HLA-A2.1 transgenic (HHDII) and BALB\/C mouse models","volume":"7","author":"Rezvan","year":"2012","journal-title":"Iran J Parasitol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-3024.2003.00626.x","article-title":"Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs)","volume":"25","author":"Delgado","year":"2003","journal-title":"Parasite Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/pmic.200800533","article-title":"Mining the Leishmania genome for novel antigens and vaccine candidates","volume":"9","author":"Herrera-Najera","year":"2009","journal-title":"Proteomics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2172-12-44","article-title":"In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection","volume":"12","author":"Pereira","year":"2011","journal-title":"BMC Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e33161","DOI":"10.1371\/journal.pone.0033161","article-title":"Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses","volume":"7","author":"Kedzierska","year":"2012","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jmr.2334","article-title":"Dynamic identification of H2 epitopes from Leishmania (Leishmania) amazonensis cysteine proteinase B with potential immune activity during murine infection","volume":"27","author":"Souza-Silva","year":"2014","journal-title":"J Mol Recognit"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1371\/journal.pntd.0001295","article-title":"In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response","volume":"5","author":"Seyed","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4172\/1948-5948.1000250","article-title":"Assessment of protection induced by DNA and live vaccine encoding Leishmania MHC class I restricted epitopes against L. major challenge in Balb\/c mice model","volume":"7","author":"Zandieh","year":"2015","journal-title":"Microb Biochem Technol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1017\/S0031182015000724","article-title":"Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection","volume":"142","author":"Costa","year":"2015","journal-title":"Parasitology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0124786","DOI":"10.1371\/journal.pone.0124786","article-title":"Prediction of CD8+ epitopes in Leishmania braziliensis proteins using EPIBOT: in silico search and in vivo validation","volume":"10","author":"Duarte","year":"2015","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0147076","DOI":"10.1371\/journal.pone.0147076","article-title":"Prediction of T cell epitopes from Leishmania major potentially excreted\/secreted proteins inducing granzyme B production","volume":"11","author":"Naouar","year":"2016","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.actatropica.2016.03.018","article-title":"Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library","volume":"159","author":"Rhaiem","year":"2016","journal-title":"Acta Trop"},{"key":"B53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2016.00327","article-title":"Combination of in silico methods in the search for potential CD4(+) and CD8(+) T cell epitopes in the proteome of Leishmania braziliensis","volume":"7","author":"Freitas e Silva","year":"2016","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1586\/1744666X.1.1.145","article-title":"Immunoinformatics and its relevance to understanding human immune disease","volume":"1","author":"Brusic","year":"2005","journal-title":"Expert Rev Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.drudis.2008.12.007","article-title":"The use of genomics in microbial vaccine development","volume":"14","author":"Bambini","year":"2009","journal-title":"Drug Discov Today"},{"key":"B57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/1471-2105-13-309","article-title":"An assessment on epitope prediction methods for protozoa genomes","volume":"13","author":"Resende","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"E371","DOI":"10.3390\/ijms18020371","article-title":"Immunoinformatics features linked to Leishmania vaccine development: data integration of experimental and in silico studies","volume":"18","author":"Brito","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/cr960065d","article-title":"Phage display","volume":"97","author":"Smith","year":"1997","journal-title":"Chem Rev"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1128\/AAC.49.7.2665-2672.2005","article-title":"Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification","volume":"49","author":"Pini","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B61","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<762::AID-IMMU762>3.0.CO;2-4","article-title":"Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites","volume":"29","author":"Courret","year":"1999","journal-title":"Eur J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/07391102.2015.1134349","article-title":"Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes","volume":"35","author":"Amit","year":"2017","journal-title":"J Biomol Struct Dyn"},{"key":"B63","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/jcb.26190","article-title":"Mining the proteome of Leishmania donovani for the development of novel MHC class I restricted epitope for the control of visceral leishmaniasis","volume":"119","author":"Dikhit","year":"2018","journal-title":"J Cell Biochem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.03.001","article-title":"Peptide immunotherapy in vaccine development: from epitope to adjuvant","volume":"99","author":"Yang","year":"2015","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis","volume":"18","author":"Goto","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1610","DOI":"10.1371\/journal.pntd.0001610","article-title":"KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi","volume":"6","author":"Gomes","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2017.00100","article-title":"A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against Leishmania amazonensis infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2016.12.008","article-title":"A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection","volume":"313","author":"Martins","year":"2017","journal-title":"Cell Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfm169","article-title":"Nanotechnology safety concerns revisited","volume":"101","author":"Stern","year":"2008","journal-title":"Toxicol Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat Mater"},{"key":"B72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ymeth.2013.04.014","article-title":"Nanovaccines and their mode of action","volume":"60","author":"Zaman","year":"2013","journal-title":"Methods"},{"key":"B74","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/en.2009-1082","article-title":"Nanoparticles and the immune system","volume":"151","author":"Zolnik","year":"2010","journal-title":"Endocrinology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3389\/fimmu.2017.00684","article-title":"A poly(lactic-co-glycolic) acid nanovaccine based on chimeric peptides from different Leishmania infantum proteins induces dendritic cells maturation and promotes peptide-specific IFN gamma-producing CD8(+) T cells essential for the protection against experimental visceral leishmaniasis","volume":"8","author":"Athanasiou","year":"2017","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.stemcr.2017.09.003","article-title":"Human induced pluripotent stem cell-derived cardiomyocyte encapsulating bioactive hydrogels improve rat heart function post myocardial infarction","volume":"9","author":"Chow","year":"2017","journal-title":"Stem Cell Reports"},{"key":"B77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1586\/erv.10.164","article-title":"Induction of anti-tumor immunity and T-cell responses using nanodelivery systems engrafting TLR-5 ligand","volume":"10","author":"Panda","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2012.05.010","article-title":"Targeting tumor antigens to dendritic cells using particulate carriers","volume":"161","author":"Joshi","year":"2012","journal-title":"J Control Release"},{"key":"B79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2016.02.018","article-title":"Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: a comparative study of cationic liposomes and PLGA nanoparticles","volume":"226","author":"Varypataki","year":"2016","journal-title":"J Control Release"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T15:30:20Z","timestamp":1693668620000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":79,"alternative-id":["10.3389\/fimmu.2018.01043"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01043","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"article-number":"1043"}}